56.3
Abeona Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
53.1
FY23:
55.7
FY24:
101
FY25:
205
(positive)
Change from FY21 to FY25
millions USD
FY21:
23.3
FY22:
11.1
FY23:
8.27
FY24:
8.08
FY25:
14.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
79.6
FY22:
64.2
FY23:
64.0
FY24:
109
FY25:
220
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.6
FY22:
7.78
FY23:
13.4
FY24:
16.6
FY25:
29.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
20.6
FY22:
29.7
FY23:
35.8
FY24:
48.3
FY25:
30.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
42.4
FY22:
26.8
FY23:
14.8
FY24:
44.0
FY25:
159
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
79.6
FY22:
64.2
FY23:
64.0
FY24:
109
FY25:
220
All amounts in millions USD